Clinical Efficacy and SAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary Intervention

PHASE4CompletedINTERVENTIONAL

Enrollment

1,500

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

ST Elevation Myocardial InfarctionPercutaneous Coronary Intervention

Interventions

DRUG

Nicorandil

6 mg nicorandil iv. just before coronary intervention, 6mg/h ivgtt. up to 48h after coronary intervention

DRUG

Placebo

placebo iv. just before coronary intervention, ivgtt. up to 48h after coronary intervention

Trial Locations (1)

Zhongshan Hospital, Shanghai

All Listed Sponsors

lead

Fudan University

OTHER